This company has been marked as potentially delisted and may not be actively trading. Can B (CANB) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock CANB vs. MEDS, BIMI, SNGX, PMCB, LIAN, PBM, XBIO, SNOA, PLRZ, and QLGNShould you be buying Can B stock or one of its competitors? The main competitors of Can B include TRxADE HEALTH (MEDS), BIMI (BIMI), Soligenix (SNGX), Nuvilex (PMCB), LianBio (LIAN), Psyence Biomedical (PBM), Xenetic Biosciences (XBIO), Sonoma Pharmaceuticals (SNOA), Polyrizon (PLRZ), and Qualigen Therapeutics (QLGN). These companies are all part of the "medical" sector. Can B vs. Its Competitors TRxADE HEALTH BIMI Soligenix Nuvilex LianBio Psyence Biomedical Xenetic Biosciences Sonoma Pharmaceuticals Polyrizon Qualigen Therapeutics TRxADE HEALTH (NASDAQ:MEDS) and Can B (NASDAQ:CANB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Is MEDS or CANB more profitable? TRxADE HEALTH has a net margin of -149.81% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat TRxADE HEALTH's return on equity.Company Net Margins Return on Equity Return on Assets TRxADE HEALTH-149.81% -196.79% -112.21% Can B -1,238.33%N/A -218.65% Which has better valuation and earnings, MEDS or CANB? Can B has lower revenue, but higher earnings than TRxADE HEALTH. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTRxADE HEALTH$7.45M0.30-$17.84M-$7.51-0.21Can B$2.16M0.89-$9.74MN/AN/A Do institutionals and insiders believe in MEDS or CANB? 5.7% of TRxADE HEALTH shares are held by institutional investors. Comparatively, 6.1% of Can B shares are held by institutional investors. 48.4% of TRxADE HEALTH shares are held by company insiders. Comparatively, 11.4% of Can B shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media refer more to MEDS or CANB? In the previous week, TRxADE HEALTH had 1 more articles in the media than Can B. MarketBeat recorded 1 mentions for TRxADE HEALTH and 0 mentions for Can B. TRxADE HEALTH's average media sentiment score of 0.00 beat Can B's score of -0.14 indicating that TRxADE HEALTH is being referred to more favorably in the media. Company Overall Sentiment TRxADE HEALTH Neutral Can B Neutral Which has more volatility & risk, MEDS or CANB? TRxADE HEALTH has a beta of 2.32, suggesting that its share price is 132% more volatile than the S&P 500. Comparatively, Can B has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500. SummaryTRxADE HEALTH beats Can B on 7 of the 11 factors compared between the two stocks. Get Can B News Delivered to You Automatically Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CANB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CANB vs. The Competition Export to ExcelMetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.91M$1.92M$6.22B$10.81BDividend YieldN/AN/A5.72%4.81%P/E RatioN/AN/A31.5430.95Price / Sales0.890.15595.06133.74Price / CashN/AN/A37.2561.86Price / Book-0.083.4912.056.61Net Income-$9.74M-$20.12M$3.34B$277.10M Can B Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CANBCan BN/A$0.02+19.9%N/A-52.5%$1.91M$2.16M0.0016Gap UpMEDSTRxADE HEALTHN/A$0.72-1.8%N/A-63.5%$1.01M$7.45M0.0050News CoverageGap DownBIMIBIMIN/AN/AN/A-98.9%$1K$12.63M0.00520SNGXSoligenix3.4465 of 5 stars$1.55-0.3%$6.00+288.3%-57.5%$6.63M$120K-0.4120Analyst ForecastGap DownPMCBNuvilex0.3129 of 5 stars$0.97-0.5%N/A-45.4%$6.60MN/A-1.804Positive NewsAnalyst ForecastShort Interest ↑LIANLianBioN/A$0.06flatN/A-75.9%$6.48MN/A-0.07110PBMPsyence Biomedical1.5383 of 5 stars$3.44-0.3%N/A-94.1%$6.45MN/A0.00N/ANegative NewsAnalyst ForecastShort Interest ↑XBIOXenetic Biosciences1.4488 of 5 stars$4.18-4.9%N/A+8.4%$6.45M$2.50M-2.094News CoverageAnalyst ForecastShort Interest ↓Gap UpSNOASonoma Pharmaceuticals1.3666 of 5 stars$3.92-4.0%N/A+33.1%$6.42M$14.29M-1.59180News CoverageAnalyst ForecastPLRZPolyrizonN/A$1.07flatN/AN/A$6.41MN/A0.00N/AAnalyst ForecastQLGNQualigen Therapeutics0.1715 of 5 stars$3.68-1.5%N/A-32.7%$6.25M$4.98M0.0050News CoverageAnalyst Forecast Related Companies and Tools Related Companies MEDS Competitors BIMI Competitors SNGX Competitors PMCB Competitors LIAN Competitors PBM Competitors XBIO Competitors SNOA Competitors PLRZ Competitors QLGN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CANB) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can B Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CANB Stock Alerts